Occudo Quantitative Strategies LP Denali Therapeutics Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$21.91 - $32.67 $640,232 - $954,650
29,221 New
29,221 $673,000
Q2 2022

Aug 15, 2022
BUY
$20.88 - $35.19 $222,831 - $375,547
10,672 New
10,672 $314,000
Q1 2021

May 14, 2021
SELL
$53.8 - $81.53 $677,288 - $1.03 Million
-12,589 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$36.89 - $93.56 $464,408 - $1.18 Million
12,589 New
12,589 $1.05 Million

Others Institutions Holding DNLI

# of Institutions
226
Shares Held
119M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.13B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email